跳至主要内容
临床试验/ACTRN12622000635763
ACTRN12622000635763尚未招募未知

A general practice delivered, diabetes technology supported, lifestyle program for Type 2 Diabetes (T2D) management – an efficacy, feasibility and acceptability evaluation Study (GP-T2D)

Commonwealth Scientific and Industrial Research Organisation (CSIRO)0 个研究点目标入组 40 人开始时间: 2022年4月29日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 18 to 75 years of age,
  • BMI of > 27kg/m2
  • identified as suitable as per clinical management needs, by their treating GP
  • medically diagnosed as having type 2 diabetes
  • willing to participate and engage with the lifestyle strategy prescribed
  • able to read, speak and understand written English (resources will be presented in English
  • willing to wear and self-manage a real-time continuous glucose monitoring device and
  • sensor, including sensor insertion and removal
  • willing to be monitored by the clinical research team
  • Access to a smart phone

排除标准

  • Have pre-existing Oncological issues
  • HbA1 >15%
  • diagnosed as having type 1 Diabetes
  • pregnant or lactating women
  • currently undergoing bariatric surgery or within the first 2 years of a bariatric surgery procedure
  • . Not willing to wear the CGM device
  • . Not willing to attend GP clinic for clinical appointments

研究者

相似试验